Handa Pharmaceuticals, Inc. (TPEX:6620)
106.00
-3.00 (-2.75%)
At close: Dec 5, 2025
Handa Pharmaceuticals Market Cap
Handa Pharmaceuticals has a market cap or net worth of 16.68 billion as of December 5, 2025. Its market cap has increased by 95.22% in one year.
Market Cap
16.68B
Enterprise Value
14.11B
Revenue
1.62B
Ranking
n/a
PE Ratio
23.39
Stock Price
106.00
Market Cap Chart
Since December 28, 2016, Handa Pharmaceuticals's market cap has increased from 8.32B to 16.68B, an increase of 100.47%. That is a compound annual growth rate of 8.09%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 258.22B |
| PharmaEssentia | 191.58B |
| Lotus Pharmaceutical | 78.89B |
| Bora Pharmaceuticals Co., LTD. | 65.31B |
| Lin BioScience | 34.87B |
| Oneness Biotech | 34.78B |
| Lumosa Therapeutics | 32.51B |
| Center Laboratories | 27.88B |